Comparative Genomic Hybridization (CGH)
Customize your policy alerts
Sign up for Aetna Policy 0787 alerts
Get alerted when Policy 0787 changes without checking for updates manually.
Monitor payer policy activity
Coverage criteria and medical necessity guidance for use of comparative genomic hybridization (CGH)/chromosomal microarray analysis for prenatal and pediatric genetic evaluation, and certain dermatologic indications; applies to Aetna members and providers.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.